Gujarat Kidney N Sup Sp L

GKSL NSE Healthcare Hospital
₹171.55
-0.96%
Delayed · cached 15 min

Fair value analysis

GKSL
Gujarat Kidney N Sup Sp L
HealthcareHospital
₹173.22
Close used for this calculation
₹55.02Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
30/100
Profitability12/25
Returns5/25
Balance Sheet11/25
Efficiency2/25
Growth0/25
Weak
Quality radar
30Prof.12/25Ret.5/25Eff.2/25B.Sht11/25Growth0/25

Consensus fair value

₹55.02
Above FV
▼ -68.2% against the close used
Model range ₹36.92 – ₹101.06
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹36.92Fair value₹55.02Bull₹101.06
FairClose
52-week traded range
52W low ₹99.3652W high ₹176.34

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Gujarat Kidney N Sup Sp L closed at ₹173.22, 214.8% above the consensus fair value of ₹55.02 drawn from 7 valuation models.

Financial DNA score 30/100 — Weak. P/E of 85.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹36.92
-78.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₹38.24
-77.9%
√(22.5 × EPS × BVPS)
EPS=1.97, BVPS=32.99 · outside Graham range (P/E 85.2, P/B 5.3) — asset-light, treat as a rough floor
P/E Fair Value
₹101.06
-41.7%
EPS × 51.3x (sector P/E)
EPS=1.97, Sector P/E=51.3x
EV/EBITDA
₹37.37
-78.4%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=320M
Book Value (P/B)
₹38.18
-78.0%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=32.99, ROE=11.1%, g=3%, r=10%
Reverse DCF
₹173.22
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 27.3% | Historical: 0%
Margin of Safety
₹44.06
-74.6%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=58.74, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.